anmelden
SMI Expanded
1.861,24
PKT
+8,36
PKT
+0,45
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.07.16 | Novartis Outperform | Bernstein Research | |
| 20.07.16 | Novartis Neutral | UBS AG | |
| 20.07.16 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.07.16 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.07.16 | Swiss Re Underperform | Credit Suisse Group | |
| 20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.07.16 | Novartis Halten | Independent Research GmbH | |
| 19.07.16 | Givaudan overweight | JP Morgan Chase & Co. | |
| 19.07.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.16 | Roche Hold | HSBC | |
| 19.07.16 | Nestlé overweight | Morgan Stanley | |
| 19.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.16 | Givaudan buy | Deutsche Bank AG | |
| 19.07.16 | Givaudan Neutral | BNP PARIBAS | |
| 19.07.16 | Givaudan Underweight | Barclays Capital | |
| 18.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.07.16 | Richemont buy | Kepler Cheuvreux | |
| 18.07.16 | Givaudan Sell | Société Générale Group S.A. (SG) | |
| 15.07.16 | UBS Hold | BB&T Capital Markets | |
| 15.07.16 | UBS Outperform | RBC Capital Markets | |
| 15.07.16 | UBS Hold | Stifel, Nicolaus & Co., Inc. | |
| 15.07.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 15.07.16 | UBS Market Perform | Cowen and Company, LLC | |
| 15.07.16 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
| 14.07.16 | Swiss Re buy | Deutsche Bank AG | |
| 14.07.16 | Holcim Neutral | BNP PARIBAS | |
| 14.07.16 | Zurich Insurance Underperform | Bernstein Research | |
| 14.07.16 | Swiss Re market-perform | Bernstein Research | |
| 14.07.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 14.07.16 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 14.07.16 | Novartis buy | Jefferies & Company Inc. | |
| 14.07.16 | Roche buy | Jefferies & Company Inc. | |
| 13.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.07.16 | UBS buy | UBS AG | |
| 12.07.16 | Roche overweight | Morgan Stanley | |
| 12.07.16 | Novartis Underweight | Morgan Stanley | |
| 12.07.16 | Holcim Hold | HSBC | |
| 12.07.16 | UBS Underperform | Bernstein Research | |
| 11.07.16 | UBS Underperform | Bernstein Research | |
| 11.07.16 | Roche overweight | JP Morgan Chase & Co. |